AI paper index

Clinic Shortlists and Sources Across ChatGPT Models and Reasoning Efforts

2026-08-29 · Zenodo (CERN European Organization for Nuclear Research)

One-line summary

An AI research paper on Clinic Shortlists and Sources Across ChatGPT Models and Reasoning Efforts.

Engineering notes

Engineering notes will be added by the aipentium editorial team.

Chinese explanation / 中文解读

中文解读待补充:本站会优先为大语言模型、生成式AI、ChatGPT相关技术、计算机视觉、深度学习等高价值论文补充中文说明。

Original abstract

Clinic Shortlists and Sources Across ChatGPT Models and Reasoning Efforts is a descriptive stability benchmark built from 450 core answers: three exact NYC commercial prompts across five ChatGPT model/reasoning configurations, with 30 isolated executions per cell. Fifteen technical preflight answers are excluded from all reported denominators. Headline within-configuration provider-set overlap was 80.3% for IVF, 34.7% for full-arch dental implants, and 53.9% for bariatric programs; corresponding visible-domain overlap was 51.1%, 28.3%, and 44.8%. The visible-source core contains 3,757 markdown-link occurrences, 3,690 unique answer-by-URL pairs, and 3,194 answer-by-domain pairs. Collection used Codex CLI 0.147.0 authenticated through one ChatGPT login with live search. It did not use the consumer ChatGPT Free/Plus UI or API-key billing. Position means presentation order, not quality ranking. Reader-visible domains do not establish causal recommendation sources. Physical US IP/location was not controlled. Boris Teplyakov reviewed the methodology as SEO Lead. This was not clinical review, peer review, a formal external audit, or an assessment of named providers. Article and full methodological context: https://rotgar.com/medical/resources/chatgpt-clinic-shortlists-model-effort-stability

5.0Engineering value
7.0Research novelty
4.0Business relevance

Links and sources

Need this topic turned into a technical roadmap?

aipentium can prepare a custom AI literature review, code map, dataset map, and B2B technology assessment.

Request B2B AI research

Comments

No comments yet. Be the first to share your thoughts on this paper.
Login or register to leave a comment